FDA Warning Letter — FitRX, LLC

Case 716501 — FEI 3040107805

The FDA took a Warning Letter action against FitRX, LLC on Sep 9, 2025 (New York, NY). The action was issued by CDER and concerns drugs products.

Action details

Facility
FitRX, LLC
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.